|
|
|
Insider
Information: |
Dobmeier Eric |
Relationship: |
President, CEO, Director |
City: |
Bothell |
State: |
WA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
730,812 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$28,060,467 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
730,812 |
|
|
Total
Value |
$28,060,467 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
13
|
3
|
Stock
price went up :
|
7
|
3
|
Stock
price went down : |
6
|
0
|
|
|
|
Gain/Loss Ratio : |
1.2
|
3.0
|
Percentage
Gain/Loss : |
17.0%
|
198.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Seagen Inc |
SGEN |
Chief Operating Officer |
2017-12-04 |
119,860 |
2004-05-05 |
0 |
Premium* |
|
Stemline Therapeutics Inc |
STML |
Director |
2017-06-19 |
27,963 |
|
0 |
Premium* |
|
Atara Biotherapeutics, Inc. |
ATRA |
|
2023-11-10 |
563,325 |
2015-12-16 |
0 |
Premium* |
|
Aravive Inc |
ARAV |
Director |
2017-12-20 |
18,160 |
2017-05-25 |
0 |
Premium* |
|
Adaptive Biotechnologies Corp |
ADPT |
Director |
2021-02-14 |
1,504 |
2019-12-26 |
0 |
Premium* |
|
Chinook Therapeutics Inc |
KDNY |
President, CEO, Director |
2023-08-11 |
0 |
2020-10-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
177 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 7 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SGEN |
Seagen Inc |
Chief Operating Officer |
|
2013-03-06 |
4 |
S |
$30.42 |
$1,520,955 |
D/D |
(50,000) |
122,948 |
0 |
- |
|
SGEN |
Seagen Inc |
Chief Operating Officer |
|
2013-03-11 |
4 |
S |
$31.15 |
$1,869,471 |
D/D |
(60,000) |
112,948 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Director |
|
2020-05-07 |
4 |
AS |
$35.00 |
$175,000 |
D/D |
(5,000) |
0 |
0 |
% |
|
ADPT |
Adaptive Biotechnologies ... |
Director |
|
2020-06-03 |
4 |
S |
$39.79 |
$198,950 |
D/D |
(5,000) |
0 |
0 |
% |
|
ADPT |
Adaptive Biotechnologies ... |
Director |
|
2020-05-19 |
4 |
AS |
$40.00 |
$200,000 |
D/D |
(5,000) |
0 |
0 |
% |
|
SGEN |
Seagen Inc |
Chief Operating Officer |
|
2015-05-08 |
4 |
S |
$40.38 |
$689,380 |
D/D |
(17,074) |
82,777 |
0 |
- |
|
SGEN |
Seagen Inc |
Chief Operating Officer |
|
2013-08-19 |
4 |
AS |
$40.91 |
$136,148 |
D/D |
(3,328) |
109,620 |
0 |
- |
|
SGEN |
Seagen Inc |
Chief Operating Officer |
|
2015-08-20 |
4 |
AS |
$42.02 |
$359,226 |
D/D |
(8,548) |
74,407 |
0 |
- |
|
SGEN |
Seagen Inc |
Chief Operating Officer |
|
2013-09-03 |
4 |
S |
$42.29 |
$2,537,664 |
D/D |
(60,000) |
135,843 |
0 |
- |
|
SGEN |
Seagen Inc |
Chief Operating Officer |
|
2015-11-06 |
4 |
S |
$42.50 |
$741,710 |
D/D |
(17,452) |
80,888 |
0 |
- |
|
SGEN |
Seagen Inc |
Chief Operating Officer |
|
2014-08-25 |
4 |
AS |
$43.55 |
$209,819 |
D/D |
(4,818) |
73,432 |
0 |
- |
|
SGEN |
Seagen Inc |
Chief Operating Officer |
|
2013-09-05 |
4 |
S |
$44.00 |
$660,000 |
D/D |
(15,000) |
135,843 |
0 |
- |
|
SGEN |
Seagen Inc |
Chief Operating Officer |
|
2013-09-10 |
4 |
S |
$46.40 |
$1,948,960 |
D/D |
(42,000) |
133,843 |
0 |
- |
|
SGEN |
Seagen Inc |
Chief Operating Officer |
|
2016-08-22 |
4 |
AS |
$46.59 |
$252,102 |
D/D |
(5,411) |
67,525 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Director |
|
2020-07-06 |
4 |
AS |
$47.34 |
$473,656 |
D/D |
(10,000) |
0 |
0 |
% |
|
SGEN |
Seagen Inc |
Chief Operating Officer |
|
2014-01-21 |
4 |
AS |
$47.87 |
$2,683,958 |
D/D |
(56,010) |
77,833 |
0 |
- |
|
SGEN |
Seagen Inc |
Chief Operating Officer |
|
2017-08-28 |
4 |
AS |
$47.89 |
$255,900 |
D/D |
(5,343) |
117,424 |
0 |
- |
|
SGEN |
Seagen Inc |
Chief Operating Officer |
|
2016-08-23 |
4 |
S |
$48.00 |
$604,272 |
D/D |
(12,589) |
58,767 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Director |
|
2020-10-01 |
4 |
AS |
$48.47 |
$485,274 |
D/D |
(10,000) |
0 |
0 |
% |
|
SGEN |
Seagen Inc |
Chief Operating Officer |
|
2017-08-31 |
4 |
S |
$52.24 |
$1,305,893 |
D/D |
(25,000) |
117,424 |
0 |
- |
|
SGEN |
Seagen Inc |
Chief Operating Officer |
|
2016-09-14 |
4 |
S |
$54.03 |
$1,238,470 |
D/D |
(22,918) |
87,767 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Director |
|
2021-01-04 |
4 |
AS |
$56.10 |
$573,369 |
D/D |
(10,000) |
0 |
0 |
% |
|
SGEN |
Seagen Inc |
Chief Operating Officer |
|
2017-11-15 |
4 |
S |
$57.80 |
$554,837 |
D/D |
(9,600) |
117,424 |
0 |
- |
|
SGEN |
Seagen Inc |
Chief Operating Officer |
|
2017-11-16 |
4 |
S |
$57.95 |
$892,637 |
D/D |
(15,400) |
117,424 |
0 |
- |
|
SGEN |
Seagen Inc |
Chief Operating Officer |
|
2017-12-04 |
4 |
S |
$58.75 |
$219,092 |
D/D |
(3,729) |
117,424 |
0 |
- |
|
177 Records found
|
|
Page 7 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|